Quantification of circulating free and circulating tumor DNA in pretreated EGFR mutant NSCLC to inform patient outcomes.

被引：0
|
作者：
Pender, Alexandra
Hughesman, Curtis
Law, Elaine
Kristanti, Amadea
McNeil, Kelly
Tucker, Tracy
Bosdet, Ian
Young, Sean
Laskin, Janessa J.
Karsan, Aly
Yip, Stephen
Ho, Cheryl
机构：
[1] British Columbia Canc Agcy, Vancouver, BC, Canada
[2] BC Canc Agcy, Dept Pathol, Vancouver, BC, Canada
[3] Univ British Columbia, Vancouver, BC, Canada
[4] BC Canc, Vancouver, BC, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9080
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Quantification of free-circulating DNA in plasma of NSCLC patients
    Szpechcinski, A.
    Maszkowska-Kopij, K.
    Kupis, W.
    Puscinska, E.
    Zaleska, J.
    Radzikowska, E.
    Orlowski, T.
    Sliwinski, P.
    Roszkowski-Sliz, K.
    Chorostowska-Wynimko, J.
    WIENER KLINISCHE WOCHENSCHRIFT, 2011, 123 (17-18) : A30 - A30
  • [2] Applications of cell-free circulating tumor DNA detection in EGFR mutant lung cancer
    Bulbul, Ajaz
    Leal, Alessandro
    Husain, Hatim
    JOURNAL OF THORACIC DISEASE, 2020, 12 (05) : 2877 - 2882
  • [3] Circulating tumor DNA analysis in patients with EGFR mutant lung cancer
    Nanjo, Shigeki
    Bivona, Trever G.
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S4061 - S4064
  • [4] Gefitinib Treatment in EGFR Mutated Caucasian NSCLC Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status
    Douillard, Jean-Yves
    Ostoros, Gyula
    Cobo, Manuel
    Ciuleanu, Tudor
    Cole, Rebecca
    McWalter, Gael
    Walker, Jill
    Dearden, Simon
    Webster, Alan
    Milenkova, Tsveta
    McCormack, Rose
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (09) : 1345 - 1353
  • [5] Association of mutant EGFR concentration in circulating cell-free DNA (cfDNA) by ddPCR with tumor burden and prognosis in NSCLC patients treated with EGFR-TKIs.
    Zhu, Yan-juan
    Zhang, Hai-bo
    Liu, Yi-hong
    Zhang, Fu-li
    Zhu, Ya-zhen
    Zheng, Guang-juan
    Chen, Jun
    Li, Yong
    Bai, Jian-ping
    Liu, Li-rong
    Qu, Yan-chun
    Qu, Xin
    Chen, Xian
    Li, Yan
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] Optimising management of EGFR mutant NSCLC through circulating tumour DNA (ctDNA) monitoring
    Powell, R.
    Kussaibati, R.
    Baijal, S.
    LUNG CANCER, 2019, 127 : S39 - S39
  • [7] Predictive Value of Circulating Tumor Cells and Circulating Free DNA in NSCLC Patients Treated with Nivolumab
    Rossi, G.
    Tagliamento, M.
    Alama, A.
    Coco, S.
    Genova, C.
    Rijavec, E.
    Barletta, G.
    Biello, F.
    Vanni, I.
    Boccardo, S.
    Dal Bello, M. G.
    Alessandra, R.
    Fontana, V.
    Grossi, F.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S730 - S731
  • [8] Circulating tumor DNA and the future of EGFR-mutant lung cancer treatment
    Del Re, Marzia
    Addeo, Alfredo
    Passaro, Antonio
    Petrini, Iacopo
    van Schaik, Ron H. N.
    Danesi, Romano
    PHARMACOGENOMICS, 2019, 20 (18) : 1255 - 1257
  • [9] Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma
    Krug, A. K.
    Enderle, D.
    Karlovich, C.
    Priewasser, T.
    Bentink, S.
    Spiel, A.
    Brinkmann, K.
    Emenegger, J.
    Grimm, D. G.
    Castellanos-Rizaldos, E.
    Goldman, J. W.
    Sequist, L. V.
    Soria, J-C
    Camidge, D. R.
    Gadgeel, S. M.
    Wakelee, H. A.
    Raponi, M.
    Noerholm, M.
    Skog, J.
    ANNALS OF ONCOLOGY, 2018, 29 (03) : 700 - 706
  • [10] Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma
    Krug, A. K.
    Enderle, D.
    Karlovich, C.
    Priewasser, T.
    Bentink, S.
    Spiel, A.
    Brinkmann, K.
    Emenegger, J.
    Grimm, D. G.
    Castellanos-Rizaldos, E.
    Goldman, J. W.
    Sequist, L. V.
    Soria, J. -C.
    Camidge, D. R.
    Gadgeel, S. M.
    Wakelee, H. A.
    Raponi, M.
    Noerholm, M.
    Skog, J.
    ANNALS OF ONCOLOGY, 2018, 29 (10) : 2143 - 2143
12345